Remove Biobanking Remove Genome Remove Medicine Remove Research
article thumbnail

Estonia National Biobank to sequence 10,000 whole genomesĀ 

Drug Discovery World

The announcement follows funding from the European Commission and the Estonian government to help Estonia adopt personalised medicine at scale and adapt public health systems to the biology of its population. To date, the samples for the Biobank have been genotyped using microarray-based methods.

article thumbnail

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What are the key trends in genomics and precision medicine for 2024?

Drug Discovery World

Leading experts in genomics, personalised medicine and drug discovery convened at the Precision Medicine Community Event in London to unveil the latest advancements shaping the future of healthcare. The post What are the key trends in genomics and precision medicine for 2024?

Genome 59
article thumbnail

Supercharging AI-drug discovery with strategic multiomic biobanksĀ 

Drug Discovery World

Narain , PhD, President and CEO of BPGbio asks how a better calibre of biobanks in life sciences can lead to more drugs making it to market. Research that once took months to complete ā€“ requiring synthesizing and testing compounds ā€“ can now be done in days and even hours using AI. But the utility of biobanks varies.

article thumbnail

Why genomic healthcare data matters in the development of new therapiesĀ 

Drug Discovery World

Genomic healthcare data is critical to identify disease risk, ancestry, traits and response to medicines and aids in the development of new targeted therapies – precision medicines. In April 2003, after its launch in October 1990, the project was completed, generating the first sequence of the human genome.

Genome 98
article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

2022 was a banner year for genomics. In March, the collaborative T2T consortium published the first complete telomere-to-telomere sequence of the human genome, filling in the last 8% of the 3 billion base pairs that make up our DNA.

Genome 116
article thumbnail

Qatar Genome Programme data improves cancer screeningĀ 

Drug Discovery World

A study by the Qatar Genome Research Consortium, led by Dr Lotfi Chouchane from Weill Cornell Medicine-Qatar, has reported the first landscape of cancer germline mutations ā€“ hereditary mutations ā€“ in the Qatari population. . These variants increase the risk of developing breast cancer in women and prostate cancer in men. .

Genome 52